Related Experiment Video
Updated: Jul 10, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Major bleeding in hemodialysis patients
Rachel M Holden1, Gavin J Harman, Miao Wang
1Division of Nephrology, Queen's University, Kingston, Ontario, Canada. holdenr@kgh.kari.net
Warfarin and aspirin significantly increase major bleeding risk in hemodialysis patients. Combination therapy poses the highest risk, necessitating careful consideration for secondary cardiovascular event prevention.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Hemorrhage risk factors in hemodialysis patients are understudied.
- Warfarin and antiplatelet agents are commonly used in this population.
- Understanding drug-related bleeding risks is crucial for patient safety.
Purpose of the Study:
- To determine the contribution of warfarin and antiplatelet agents to major bleeding incidence in hemodialysis patients.
- To quantify the risk of first major bleeding events associated with these medications.
Main Methods:
- Retrospective chart review of hemodialysis patients.
- Calculation of incidence rates based on exposure time.
- Use of time-dependent covariates and Cox proportional hazard models.
Main Results:
- Major bleeding incidence was 2.5% per person-year.
- Warfarin exposure: 3.1% incidence; Aspirin exposure: 4.4% incidence.
- Combination therapy (warfarin + aspirin) showed a 6.3% incidence, with a hazard ratio of 6.19.
Conclusions:
- Aspirin and/or warfarin significantly elevate major bleeding risk in hemodialysis patients.
- Warfarin monotherapy did not reach statistical significance for increased bleeding risk.
- Further research is needed to assess the efficacy of these agents for secondary cardiovascular prevention in this high-risk group.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Hemodialysis III: Nursing Management
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications